Clinical Trials Directory

Trials / Completed

CompletedNCT04106986

The Effect Of Pulsed Electromagnetic Field And Progressive Resistance Exercise On Knee Osteoarthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Jordan University of Science and Technology · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effect of pulsed electromagnetic field and progressive resistance exercise on Knee Osteoarthritis. It is experimental research study that look at the additive effect of pulsed electromagnetic field and progressive resistive exercise on pain level, patient-reported and performance-based physical function and Quality of life for patients with knee osteoarthritis

Detailed description

Background: osteoarthritis is the main cause of disability in elderly population.\[1,2\] It affects almost one third of individuals aged 65 and older and approximately 25% of osteoarthritis patients 60 years and older cannot perform activities of daily living.\[3\] The clinical symptoms that lead to disability in Knee osteoarthritis are more frequent than all other joint complaint. A large body of evidence exists proving the beneficial effects of progressive resistance exercise (PRE) in patients with knee osteoarthritis (OA).\[4,5,6\] Pulse electromagnetic field(PEMF) is a physical therapy modality that could be used for treating knee osteoarthritis (OA) and there emerging evidence suggesting its beneficial effect in reducing pain and improving function for knee osteoarthritis (OA)\[7\] The purpose of the study is to examine the effectiveness of using pulsed electromagnetic field (PEMF) with progressive resistance exercise (PRE) training in decreasing pain level ,improving physical function, and improving quality of life in patients with Knee osteoarthritis (OA) A small randomized control trial conducted to recruit 32 patients with knee osteoarthritis (OA). Participants with knee osteoarthritis (OA) as defined by American College of Rheumatology recruited from Prince Basma Educational Hospital. Eligible patients were randomly assigned to receive 24 sessions (3 sessions/week for 8 weeks) of either the combined (PRE and PEMF) treatment or PRE only. Participants will be evaluated at baseline, after the end of treatment protocol (8 weeks), and at 3 and 6 months follow up. Mixed ANOVA and repeated measure ANOVA will be used to evaluate the differences between groups in pain, and physical function, and quality of life

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTPulsed electromagnetic field and Progressives resistance exerciseThe pulsed electromagnetic field treatment consist of 30 minutes pulsed electromagnetic field with 50 Hz pulses The progressive resistance exercise training consist of 45 minutes of progressive resistance exercise protocol as the following: The PRE session begun with warm-up exercises that included riding a stationary ergometer for 5 minutes followed by stretching exercises for the hamstrings, quadriceps and gastrocnemius muscles. After this, subjects performed non-weight bearing (open chain) and weight bearing (closed chain) quadriceps exercises. The amount of resistance and number of repetitions for each exercise are based on a modification of the daily adjustable progressive resistance exercise (DAPRE) program that was described by Knight eta al.
OTHERPREThe progressive resistance exercise training consist of 45 minutes of progressive resistance exercise protocol as the following: The PRE session begun with warm-up exercises that included riding a stationary ergometer for 5 minutes followed by stretching exercises for the hamstrings, quadriceps and gastrocnemius muscles. After this, subjects performed non-weight bearing (open chain) and weight bearing (closed chain) quadriceps exercises. The amount of resistance and number of repetitions for each exercise are based on a modification of the daily adjustable progressive resistance exercise (DAPRE) program that was described by Knight eta al.

Timeline

Start date
2019-03-24
Primary completion
2020-01-22
Completion
2020-01-22
First posted
2019-09-27
Last updated
2021-12-14

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04106986. Inclusion in this directory is not an endorsement.